AbbVie Signs Licensing Deal With Sirona Biochem For Effective New Hydroquinone Alternative
AbbVie acquires the rights to market and commercialize Sirona’s breakthrough TFC-1067 compound AbbVie agrees to upfront, milestone, and royalty payments for patented molecules Sirona’s TFC-1067 is expected to become the new gold standard for skin
Read More
The post AbbVie Signs Licensing Deal With Sirona Biochem For Effective New Hydroquinone Alternative appeared first on Zex PR Wire…
Read More
0
